OPARIL SUZANNE 4
4 · ENCYSIVE PHARMACEUTICALS INC · Filed Jan 10, 2005
Insider Transaction Report
Form 4
OPARIL SUZANNE
Director
Transactions
- Other
Common Stock
2005-01-10$10.06/sh+745$7,495→ 14,969 total
Footnotes (1)
- [F1]Common Stock issued in lieu of Board of Directors fees.